Sprint Bioscience AB (SPRINT) — Capital Reinvestment Ratio
Sprint Bioscience AB (SPRINT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr115.84 Million) in capital expenditures (Skr65.00K). See Sprint Bioscience AB net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sprint Bioscience AB Capital Reinvestment Ratio (2015–2025)
This chart tracks Sprint Bioscience AB's Capital Reinvestment Ratio across 4 annual periods. Check SPRINT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sprint Bioscience AB (2015–2025)
Year-by-year Capital Reinvestment Ratio for Sprint Bioscience AB from 2015 to 2025. For live market cap and broader valuation context, see market cap of Sprint Bioscience AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | Skr83.53 Million | Skr94.00K | ▼ -99.0% |
| 2023 | 0.11x | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 1.25x | Skr7.93 Million | Skr9.91 Million | ▼ -83.2% |
| 2015 | 7.43x | Skr833.54K | Skr6.19 Million | — |